Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D9VR6X
|
|||
| Drug Name |
Sapablursen
|
|||
| Drug Type |
Ligand-conjugated antisense
|
|||
| Indication | Polycythemia vera [ICD-11: 2A20.4; ICD-10: D45] | Phase 2 | [1] | |
| Company |
Ionis
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | TMPRSS6 messenger RNA (TMPRSS6 mRNA) | Target Info | . | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT05143957) A Phase 2a, Randomized, Open-Label Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ISIS 702843 Administered to Patients With Phlebotomy Dependent Polycythemia Vera (PD-PV). U.S.National Institutes of Health. | |||
| REF 2 | Clinical pipeline report, company report or official report of Ionis | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.